Empowering Collaborative Innovation Through Research: QYM/SURFTECH Visit Anhui Medical University to Deepen Technological Cooperation in Colorimetric substrates

On Jan. 8, Sam, the Business Director of QYM/SURFTECH, led the core team to visit the Scientific Research and Experiment Center of our partner, Anhui Medical University. The team conducted in-depth technical and business exchanges with Dr. Lu and members of the laboratory, and paid an on-site visit to the Key Laboratory of Anti-inflammatory and Immunomodulatory Drugs of the Ministry of Education.

Focusing on core technological innovation and achievement transformation in the field of IVD substrates, including substrate for γ-glutamyltransferase (GGT)- L-γ-Glutamyl-3-carboxy-4-nitroanilide ammonium salt (Glupa-C); substrate for alkaline phosphatase (ALP)- 4-Nitrophenyl Phosphate (p-NPP)

; 4,6-Ethylidene-4-nitrophenyl-1,4-α-D-Maltoheptaoside (EPS-G7); chemiluminescent substrate for alkaline phosphatase (APase)- 3-(2'-Spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane (AMPPD). This visit systematically demonstrated our company's business strengths. The two parties reached multiple consensuses on subsequent joint research and business cooperation, further consolidating the university-enterprise cooperation pattern featuring complementary advantages.

This visit serves as an important measure to deepen university-enterprise collaborative innovation. Moving forward, the two parties will establish a regular R&D communication mechanism, integrate the business advantages of the enterprise with the academic resources of the university, and conduct in-depth cooperation in technical research and development as well as achievement transformation. These efforts will promote the commercialization of high-value-added biomaterial technologies and contribute to the high-quality development of the industry.